Actos News

Studies Show an Increase in Bladder Cancer for Actos Patients
Friday, August 26, 2011

American Diabetes Association study published in Diabetes Care issue shows increased risk of bladder cancer in patients taking Actos (pioglitazone). Researchers gathered data taken from the U.S. Food and Drug Administration's (FDA) Adverse Event Reporting System (AERS) between 2004 and 2009.



News Archives

Actos News 2014
Actos News 2013
Actos News 2012
Actos News 2011

Tell Us What
Happened to You

*Confirm Email
This field must be blank
*Describe your symptoms